Le Lézard
Classified in: Health
Subject: SVY

Global Pharmaceutical Formulations Procurement Market Report 2017 - Top Suppliers are Pfizer CentreOne, Mylan, Boehringer Ingelheim, Lonza & Baxter


DUBLIN, Dec. 7, 2017 /PRNewswire/ --

The "Global Pharmaceutical Formulations - Procurement Market Intelligence Report" report has been added to Research and Markets' offering.

Research and Markets Logo

Global Pharmaceutical Formulations Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

The pharmaceutical industry has been demonstrating excellence in new product development such as reformulations of existing drugs for better customer acceptance or novel formulation approaches to enhance bioavailability and reduce time to market. Formulation enhancements can help in reducing the frequency of administration. The use of new delivery technologies can significantly improve patient experience, reduce the volume required for each dosage, and minimize the side-effects associated with the formulation.

One of the procurement best practices for buyers in the global pharmaceutical formulations market is to is to use DOE for formulation development. Buyers should engage with suppliers that use DOE, which is an effective tool and can be useful in the entire formulation process.

According to the report, one of the key growth drivers for the global pharmaceutical formulations market is the developments in formulation enhancements which can help in reducing the frequency of administration. The use of new delivery technologies can significantly improve patient experience, reduce the volume required for each dosage, and minimize the side-effects associated with the formulation.

Further, the report states that one of the key procurement challenges faced by buyers is problems of non-compliance by suppliers. Pharmaceutical companies are required to follow a host of regulations in the region of operation as well as are subject to scrutiny by global regulatory agencies.

Key Topics Covered:

PART 1: CATEGORY AT A GLANCE

PART 2: SCOPE OF THE REPORT

PART 3: MARKET INSIGHTS





PART 4: SUPPLY MARKET INSIGHTS

PART 5: PRICING INSIGHTS

PART 6: PROCUREMENT INSIGHTS

PART 7: TOP FIVE SUPPLIERS

For more information about this report visit https://www.researchandmarkets.com/research/sjqs37/global

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 




These press releases may also interest you

at 09:00
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5374, a phase 1/2a study evaluating the safety, tolerability, and antiviral effect of a novel combination regimen that includes...

at 09:00
PureTalk, a nationwide cell phone service provider offering premium wireless service at a fair price on the nation's most dependable 5G network, today celebrates over $100,000 customer donations to the America's Warrior Partnership (AWP). Since...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 09:00
On 5 April 2024, SciBase Holding AB (publ) ("SciBase" or the "Company") announced that the Board of Directors, with the support of the authorization granted by the annual general meeting held on 17 May 2023, had resolved on a rights issue of units,...

at 09:00
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that Galentm Breast HER2 has been named a bronze winner of the 2024 Edison Awards in the Diagnostic Technologies category. The awards, named after inventor...

at 09:00
Collective bargaining for registered nurses (RNs) and health-care professionals with the province's for-profit nursing homes has broken down just three days into five days of scheduled negotiations, with no deal reached, says the Ontario Nurses'...



News published on and distributed by: